Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Apelin/APLNR system modulates tumor immune response by reshaping the tumor microenvironment. | Gene | 2022 | 35598689 | PubTator, text mining | PubMed |
Value of Immunohistochemical Expression of Apelin, Succinate Dehydrogenase B, Chromogranin B, Human Epidermal Growth Factor Receptor-2, Contactin 4, and Succinyl-CoA Synthetase Subunit Beta in Differentiating Metastatic From Non-Metastatic Pheochromocytoma and Paraganglioma. | Front Endocrinol (Lausanne) | 2022 | 35574028 | PubTator, text mining | PubMed |
| CD1d expression demarcates CDX4+ hemogenic mesoderm with definitive hematopoietic potential. | Stem Cell Res | 2022 | 35569347 | PubTator, text mining | PubMed |
| Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression. | Cancers (Basel) | 2022 | 35565396 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Gene Expression Associated with Granulosa Cell Tumor Development in a Mouse Model. | Cancers (Basel) | 2022 | 35565312 | PubTator, text mining | PubMed |
| Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus. | Int J Mol Sci | 2022 | 35563635 | PubTator, text mining | PubMed |
| APJ/apelin: A promising target for the treatment of retinopathy of prematurity. | Drug Discov Today | 2022 | 35561966 | PubTator, text mining | PubMed |
| CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives. | Theranostics | 2022 | 35547744 | PubTator, text mining | PubMed |
| On Methods for the Measurement of the Apelin Receptor Ligand Apelin. | Sci Rep | 2022 | 35546171 | PubTator, text mining | PubMed |
| Novel brown adipose tissue candidate genes predicted by the human gene connectome. | Sci Rep | 2022 | 35534514 | PubTator, text mining | PubMed |
| Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis. | BMC Pediatr | 2022 | 35501731 | PubTator, text mining | PubMed |
| Endothelial Dysfunction and Diabetic Cardiomyopathy. | Front Endocrinol (Lausanne) | 2022 | 35464057 | PubTator, text mining | PubMed |
| Development and Validation of Novel Prognostic Models for Immune-Related Genes in Osteosarcoma. | Front Mol Biosci | 2022 | 35463956 | PubTator, text mining | PubMed |
| Bioinformatics of Differentially Expressed Genes in Phorbol 12-Myristate 13-Acetate-Induced Megakaryocytic Differentiation of K562 Cells by Microarray Analysis. | Int J Mol Sci | 2022 | 35457039 | PubTator, text mining | PubMed |
| Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration. | Pharmaceutics | 2022 | 35456545 | PubTator, text mining | PubMed |
| TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook. | Oxid Med Cell Longev | 2022 | 35450411 | PubTator, text mining | PubMed |
| Lena Ho: Micropeptides under the spotlight. | J Cell Biol | 2022 | 35442399 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Endothelial progenitor cells stimulate neonatal lung angiogenesis through FOXF1-mediated activation of BMP9/ACVRL1 signaling. | Nat Commun | 2022 | 35440116 | PubTator, text mining | PubMed |
| Surgical treatment of ductal biliary recurrence of poorly cohesive gastric cancer mimicking primary biliary tract cancer: a case report. | J Surg Case Rep | 2022 | 35422987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=28